newsfilter
← Latest News
Business Wire·

QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention

New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various settings Findings show QuantiFERON testing is cost-effective compared with tuberculin skin testing in